🇺🇸 FDA

Intelligence · Patent portfolio

NORTHWEST BIOTHERAPEUTICS Patents

Full USPTO pharma patent portfolio for NORTHWEST BIOTHERAPEUTICS — grant dates, expiration, and drug cross-links.

Patents
595
Expiring ≤24m
13

Quick answer

NORTHWEST BIOTHERAPEUTICS has 595 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 13 expire within 24 months — use filters for patent-cliff planning.

Page 10 of 13

  1. US 8735075

    Cancer screening by detection of ultrastructural and molecular markers

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8722939

    Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8710032

    Inhibitors of the mevalonate pathway of Streptococcus pneumoniae

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8709444

    Live-attenuated compositions for bacterial infections

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8697048

    Peptide amphiphile suspension to prevent or reduce tumor formation from administered embryonic stem cells

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8697076

    Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8686041

    Inhibition of ornithine aminotransferase for the treatment of proliferative disorders

    Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8685538

    Stable polyelectrolyte coated nanoparticles

    Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8673843

    NMDA receptors modulators and uses thereof

    Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8586044

    Treatment of chronic pelvic pain syndrome

    Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8580231

    Compositions and methods comprising magnetic resonance contrast agents

    Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8580923

    Self-assembling peptide amphiphiles and related methods for growth factor delivery

    Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8557290

    Multifunction nanoconjugates for imaging applications and targeted treatment

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8557552

    Selective neuronal nitric oxide synthase inhibitors

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8551726

    Method of modulating HSF-1

    Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8545813

    Pre-templated macromolecular architectures with multiple Gd(III) complexes and methods of use as MRI contrast agents

    Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8524655

    Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8518636

    Tangential flow filtration devices and methods for leukocyte enrichment

    Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8518884

    Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha inhibitor

    Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8512693

    Self-assembling membranes and related methods thereof

    Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8492345

    Cyclic peptide antitumor agents

    Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8492340

    Methods of treating depression and other related diseases

    Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8481035

    Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8481760

    Inhibition and treatment of prostate cancer metastasis

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8465746

    Compositions and methods for treatment, research and therapeutic applications for malaria

    Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8450271

    Peptide-based scaffolds for cartilage regeneration and methods for their use

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8426179

    Synthetic peptide and peptide conjugates and related tissue coupling methods via transglutaminase enzyme

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8425653

    Plasmon mediated photoinduced synthesis of silver triangular bipyramids

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8420665

    Anti-cancer compounds

    Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8409602

    Sealants for fetal membrane repair

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8409566

    Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8404264

    Functionalizing implantable devices with a poly (diol citrate) polymer

    Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8389731

    Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase

    Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8383113

    Anti-ADDL antibodies and uses thereof

    Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8367672

    Pyridazine compounds, compositions and methods

    Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8337813

    Contrast agents

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8334272

    Methods for nucleic acid transfer into cells

    Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8323686

    Nanostructures suitable for sequestering cholesterol and other molecules

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8299100

    Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane permeability

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8278305

    Myosin light chain kinase inhibitor compounds, compositions and related methods of use

    Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8278084

    Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition

    Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8252756

    Nucleic acid functionalized nanoparticles for therapeutic applications

    Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8246983

    Encapsulated arsenic drugs

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8241862

    Perinucleolar compartment as a cancer marker

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8198406

    Methods and compositions for inhibiting angiogenesis

    Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8193151

    Methods for treating atrial or ventricular arrhythmias

    Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8188096

    Protein kinase targeted therapeutics

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8173628

    Steroidal antiestrogens and antiandrogens and uses thereof

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does NORTHWEST BIOTHERAPEUTICS have?

595 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do NORTHWEST BIOTHERAPEUTICS patents expire?

13 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.